DNA Base Excision Repair Modeling Cellular Biosystem Engineering - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

DNA Base Excision Repair Modeling Cellular Biosystem Engineering

Description:

Accurately diagnosing problems with a cellular process and controlling it to ... at low substrate formation rates, and may enhance repair through 'baton passing' ... – PowerPoint PPT presentation

Number of Views:187
Avg rating:3.0/5.0
Slides: 28
Provided by: bahradso
Category:

less

Transcript and Presenter's Notes

Title: DNA Base Excision Repair Modeling Cellular Biosystem Engineering


1
DNA Base Excision Repair ModelingCellular
Biosystem Engineering
  • Bahrad A. Sokhansanj
  • School of Biomedical Engineering
  • Drexel University
  • Greater Philadelphia Bioinformatics Alliance
  • BMES 2004 Computational Biology Workshop
  • Oct. 13, 2004

2
Biological functions are controlled and
implemented by complex systems
  • Multiple molecules interacting in different ways
    at different scales
  • reaction
  • combination
  • transformation
  • communication
  • Accurately diagnosing problems with a cellular
    process and controlling it to enhance function or
    mitigate dysfunction requires understanding how
    changing one or more factors affects the whole
    system
  • Factors contribute unequally and dynamically
    (Biological systems are NEITHER binary NOR steady
    state)

3
DNA Base Excision Repair
http//greengenes.llnl.gov/repair/html/overview.ht
ml
4
Hypothesis Individual responses to DNA damage
are determined by multiple genes coding proteins
with different non-essentially modified functions
http//greengenes.llnl.gov/repair/html/overview.ht
ml
5
DNA damage and repair are phenotypes that can be
quantitatively measured
  • Purified wt BER proteins are available and
    protocols exist to obtain whole cell, nuclear,
    and mitochondrial extracts
  • Fluorescent and radio-labeled oligos with damaged
    sites (visualized on gels length difference
    measures repaired)
  • Damage sites may be incorporated in specific
    restriction sites to measure repair intermediates
  • Molecular beacons (fluorescent stem loop oligos)
    may be used for in vivo (!) measurements of
    repair kinetics
  • Actual cellular DNA damage single cell gel
    electrophoresis Comet Assay (different damage
    sites are measured after enzymatic treatment,
    e.g. by Fpg, to produce strand breaks)
  • GC/LC-MS techniques are also available (elevated
    damage measurements due to artifacts, but may be
    useful for relative quantification)

6
In vitro Repair Kinetic Assays
S.L. Allinson et al. /DNA Repair 3 (2004) 2331
7
In vivo Repair Kinetic Assays
A. Maksimenko et al. /Bioch. Biophys. Res. Comm.
319 (2004) 240246
8
Base Excision Repair (BER) Pathway
9
In vitro Pathway ReconstitutionAP (abasic) site
repair
... compared with an in vitro pathway reconstruct
ion (Srivasta, et al. 1998).
10
Ape1-Polb Cooperativity
11
Polb Coordination
  • consecutive dRp lyase and gap-filling steps may
    be coordinated by the same Polb enzyme

12
Polb Coordination
13
Changing the Initial Number of Adducts(Im
starting to do this dynamically)
14
Whole Cell BER Model
15
Whole Cell BER Model
16
Parameters are from Experimental Data
17
Comparison with Cell Extract Assays
Supports hypothesis of Ape1-Ogg1
interaction8-oxoG lt U lt AP site repair rate
18
Short Patch Repair Dominates BER(depends on rx
conditions, substrate?)
19
Steady State Endogenous Lesion Formation
  • AP Site Formation (spontaneous hydrolysis)
  • 2-10,000 apurinic, 100-500 apyrimidinic
    sites/cell/day
  • 8-oxoG Formation (metabolic ROS)
  • 100-500 sites/cell/day
  • Other oxidative base damage
  • 20-100 sites/cell/day
  • Does this mean there is a significant background
    level of unrepaired intermediate repair
    lesions?
  • Experimental measurements vary from 500 to
    200,000 AP or 8-oxoG sites/cell (cell type
    differences? experimental artifacts?)
  • Steady state BER model simulated for normal
    endogenous damage rates (focus on 8-oxoG repair)

20
Experimental data for steady state oxidative DNA
lesion levels
Pouget, et al., Chem. Res. Toxicol., 13 541, 2000
Dizdaroglu, Free Radic. Medic. Biol., 32 1102,
2002
21
Steady State Predictions
Breaking point of about 125,000
8-oxoG/cell/day. (900 s.s. lesions/cell)
22
Dependence on Formation Rate
23
Sensitivity Analysis Results Are Robust
24
Why support lower experimental estimates?
  • Assumptions of the modeling
  • Michaelis-Menten kinetics, exclusion of product
    inhibition
  • but, product inhibition is unlikely to be a
    factor at low substrate formation rates, and may
    enhance repair through baton passing
  • Only considered AP site and 8-oxoG repair
  • but, cytosine deamination, SSB, etc. occur at
    substantially lower levels, and kinetics are not
    much slower
  • they can also be included in the model, with more
    data
  • Mitochondria may be a source of lesions from ROS
  • at least 100-fold fewer bases in mitochondria vs.
    nucleus
  • experimental studies show insignificantly higher
    levels of damage in mitochondria, and possibly
    faster repair kinetics
  • Chromatin structure effects in vivo
  • recent studies show substantially lower Polb and
    DNA ligase activity (in vitro and in vivo)
  • we are currently incorporating this in our
    modeling

25
Next step Measuring relative BER capacity for
protein variants found in population
26
Proposed Experiments for BER Variability
  • Cell lines with known BER protein sequences /
    expression (Coriell Institute HapMap Project)
  • Measure repair kinetics (repair time course) in
    vitro (circular and linear oligoDNA) and in vivo
    (molecular beacons) and capacity (DNA damage dose
    response by SCGE)
  • Measure changes/differences in protein/gene
    expression
  • Computational sequence analysis has predicted
    potential protein function variants (Jones
    Mohrenweiser)
  • Perturb cells by overexpressing repair proteins
    and adding purified proteins to cell extracts
    interpret results using our Whole Cell BER Model
  • Current collaborators Irene Jones (LLNL), Harvey
    Mohrenweiser (UC-Irvine), David Wilson (NIA)

27
Acknowledgements
  • David M. Wilson, III (NIH-National Institute on
    Aging)
  • Irene Jones (BBRP) and Harvey Mohrenweiser
    (UC-Irvine)
  • Yoshimura Matsumoto (Fox Chase Cancer Center)
  • Emerging collaborations at Drexel and Beyond
  • bahrad.sokhansanj_at_drexel.edu
Write a Comment
User Comments (0)
About PowerShow.com